PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials

Meng, XJ; Chen, Y; Xing, LG; Liu, XC; Zhao, KK; Jiang, LY; Zhang, L; Zhou, CC; Yu, JM

Yu, JM (通讯作者),Shandong Univ, Canc Ctr, Jinan, Shandong, Peoples R China.;Yu, JM (通讯作者),Shandong First Med Univ & Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China.;Yu, JM (通讯作者),Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Key Lab Radiat Oncol, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China.;Zhang, L (通讯作者),Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China.;Zhou, CC (通讯作者),Tongji Un

BMJ OPEN RESPIRATORY RESEARCH, 2022; 9 (1):

Abstract

Background To date, none of randomised trials aim to compare the efficacy of programmed death 1 (PD-1) inhibitor plus chemotherapy and bevacizumab plu......

Full Text Link